617 filings
Page 7 of 31
S-8
ux0du
3 Sep 21
Registration of securities for employees
8:00am
8-K
xfwpou17m9cgw42t
2 Aug 21
VBI Vaccines Announces Second Quarter 2021 Financial Results and Provides
8:00am
8-K
8ogwc4g6m7p2precy
7 Jul 21
VBI Vaccines Appoints Linda Bain to Board of Directors
9:25am
8-K
xppjiccocq kak
1 Jul 21
VBI Vaccines Reports New CPT Code Issued for a 3-Antigen Prophylactic Hepatitis B Vaccine
4:34pm
8-K
paija4hs fdoq03o
29 Jun 21
VBI Vaccines Announces Initial Positive Phase 1 Data for its eVLP Vaccine Candidate Against COVID-19
7:35am
8-K
rmdwt7 vp7v235x21jws
23 Jun 21
Regulation FD Disclosure
7:00am
8-K
0agnb mhnb
17 Jun 21
VBI Vaccines to Present at Upcoming Scientific Conferences
8:00am
8-K
ggimt7c8e1ee69hq
10 Jun 21
VBI Vaccines Announces Results of Annual General Meeting
12:00am
8-K
5xau13bhtg
9 Jun 21
VBI Vaccines Announces Multiple Abstracts Accepted for Poster Presentations at About Hepatitis B
8:00am
8-K
dsyd9
8 Jun 21
VBI Vaccines Granted FDA Fast Track Designation for VBI-1901 for the Treatment of Recurrent GBM
8:00am
8-K
wlv4xk2k
1 Jun 21
VBI Vaccines to Participate in Upcoming Investor Conferences
8:30am
8-K
d7z5rc5n
21 May 21
VBI Vaccines Announces $12 Million Second Tranche of Debt Financing with K2 HealthVentures
8:00am
8-K
ncyevgs vi5n2ol
20 May 21
VBI Vaccines to Present Updated Phase 2a Tumor Response and Overall Survival Data for VBI-1901 in Recurrent GBM at 2021 ASCO Annual Meeting
8:00am
8-K
14y 48g9np
12 May 21
Regulation FD Disclosure
8:00am
8-K
8mx6ey1ymx 0d
10 May 21
VBI Vaccines Announces First Quarter 2021 Financial Results and Provides Corporate Update
8:00am
8-K
7vmcq
3 May 21
VBI Vaccines Announces Multiple Presentations at the Canadian Liver Meeting 2021
9:00am
8-K
xpzg78qg1y5rzck6w
28 Apr 21
Regulation FD Disclosure
8:00am
8-K
m0zi0w7o
27 Apr 21
VBI Vaccines to Participate in National Securities Corporation’s Biotech Investor Summit
9:31am